{"id":64398,"date":"2025-02-06T12:01:45","date_gmt":"2025-02-06T12:01:45","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/06\/opthea-wet-amd-data-featured-at-macula-society-meeting\/"},"modified":"2025-02-06T12:01:45","modified_gmt":"2025-02-06T12:01:45","slug":"opthea-wet-amd-data-featured-at-macula-society-meeting","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/","title":{"rendered":"Opthea Wet AMD Data Featured at Macula Society Meeting"},"content":{"rendered":"<div>\n<p align=\"justify\">MELBOURNE, Australia, and PRINCETON, N.J., Feb.  06, 2025  (GLOBE NEWSWIRE) &#8212; Opthea Limited (ASX\/NASDAQ:OPT, \u201cOpthea\u201d, the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that sozinibercept will be highlighted during an oral presentation at the Macula Society 48<sup>th<\/sup> Annual Meeting being held\u00a0\u00a0 February 12-15, 2025 in Charlotte Harbor, Florida. The Macula Society is a forum for new research in retinal vascular and macular diseases.<\/p>\n<p align=\"justify\">Details are as follows:<\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:15%; width:15%; min-width:15%;;vertical-align: top ; \">Session:<\/td>\n<td style=\"max-width:85%; width:85%; min-width:85%;;vertical-align: top ; \">Neovascular AMD I: Trials<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">Timing:<\/td>\n<td style=\"vertical-align: top ; \">Friday, February 14, 2025, 8:00 to 8:05 AM ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">Presentation:<\/td>\n<td style=\"vertical-align: top ; \">Sozinibercept Combination Therapy for Neovascular Age-Related Macular Degeneration: Subgroup Analysis of a Phase 2b Study to Assess the Angiographic Predictors of Response<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">Presenter:<\/td>\n<td style=\"vertical-align: top ; \">David S. Boyer, MD<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">Program:<\/td>\n<td style=\"vertical-align: top ; \"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=COedYF2BFajQ7jfkxejzaXca_BoN0wPTHJB1cgZWWO6ZBmA8I5Xlw9b4YHIFxHvPKUKYif3GsrMNSFD6J49O4StOs8mOWF7aFK0qIj1RCzWbHKhkPotIy_DXMf1AcgkW6qGMmFDzL1kEBR74egnwkqsRH8zqWnBVbieusyO16xV42oENrF1FD95fMzjjY6p_hQr-KWQZ2Fl717YbOPbnuhnwYdxOops2B7GBNqbXswugTE4sUY1CsCCT1UYmUINgh5bf2GIpowV4FDyfG1mBR9XvFrwjj1kNvUHE1-PvDZA=\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/www.xcdsystem.com\/maculasociety\/program\/5G2onFx\/index.cfm?pgid=397&amp;RunRemoveSessionFilter=1<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<td style=\"vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">David S. Boyer, MD will present data from the sozinibercept Phase 2b wet AMD trial demonstrating that superior vision and anatomic outcomes were observed with sozinibercept 2 mg combination therapy, compared with standard-of-care ranibizumab alone, with baseline angiographic lesion characteristics predictive of response.<\/p>\n<p align=\"justify\"><strong>About Opthea<\/strong><\/p>\n<p align=\"justify\">Opthea (ASX\/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age\u2010related macular degeneration (wet AMD) and diabetic macular edema (DME), which remain leading causes of vision loss worldwide.<\/p>\n<p align=\"justify\">Opthea\u2019s lead product candidate in Phase 3 development, sozinibercept, is a first-in-class VEGF-C\/D \u2018trap\u2019 inhibitor being evaluated in combination with standard-of-care anti-VEGF-A therapies to deliver superior vision to wet AMD patients. Sozinibercept has the potential to become the first therapy in 20 years to enable patients with wet AMD live fuller and healthier lives.<\/p>\n<p>To learn more, visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WvXLjMBfGCC552D8H_nrbR9Of9dFgDlJJ65p2m7x4ZzDTGaQt5SbTeNUtMbpE9GXD9jD7bz8VNAcE3admcRaJg==\" rel=\"nofollow\" target=\"_blank\" title=\"www.opthea.com\">www.opthea.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rJYqmD5fNPnczR2oW9Cf9R5erVjBtZx6dXoUrQdQ0r21PbyQgXb-PrNprjAPr_Lxiz1FtYZ61VdkOs4Tct2pNw==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uiAS7DWAJ5rKz2ejDCcxuTCtTYUmFioa5S6s1AG3TyS_UeqKJZGzVhoxZpgqjZtUqOP_zNeguT974KwswhqEp0Ggo5ybjaQiMxjRg0-MpxU=\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">Authorized for release to ASX by Frederic Guerard, PharmD, CEO<\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><strong>Investor Inquiries<\/strong><\/p>\n<p>PJ Kelleher\u00a0<br \/>LifeSci Advisors, LLC\u00a0<br \/>Email: <a href=\"mailto:pkelleher@lifesciadvisors.com\" rel=\"nofollow\" target=\"_blank\" title=\"pkelleher@lifesciadvisors.com\">pkelleher@lifesciadvisors.com<\/a> <br \/>Phone: 617-430-7579\u00a0<\/td>\n<td style=\"text-align: justify ;  vertical-align: middle; vertical-align: top ; \"><strong>Media\u00a0Inquiries<\/strong>\u00a0<\/p>\n<p>Silvana Guerci-Lena\u00a0<br \/>NorthStream Global Partners\u00a0<br \/>Email: <a href=\"mailto:silvana@nsgpllc.com\" rel=\"nofollow\" target=\"_blank\" title=\"silvana@nsgpllc.com\">silvana@nsgpllc.com<\/a>\u00a0<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<td style=\"text-align: justify ;  vertical-align: middle; vertical-align: top ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">Join our email database to receive program updates:\u00a0\u00a0<br \/>Tel: +61 (0) 3 9826 0399, Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xROu_mE4z4cQU6Chk3bFj-gPghVvWRaAwf9tFF-gCHKDtrwT35Y-CPf-SqT1SPAqjLTW6mLiGR1iC-mYT4vXiA==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>info@opthea.com<\/u><\/a> Web: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WvXLjMBfGCC552D8H_nrbf-6flRjED2Xrcn0B_H0wbY8np2GluNabVQB2RwxW7EtvOeYFjBou-FRu4mtUfdOwA==\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>www.opthea.com<\/u><\/a>\u00a0\u00a0\u00a0<\/p>\n<p align=\"justify\">Source: Opthea Limited<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODdlM2EzNjEtYzBiYi00NjI4LTk4YjQtYjc3NWU1NDY5NWViLTUwMDEyMTgwNg==\/tiny\/Opthea-Limited.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MELBOURNE, Australia, and PRINCETON, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Opthea Limited (ASX\/NASDAQ:OPT, \u201cOpthea\u201d, the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that sozinibercept will be highlighted during an oral presentation at the Macula Society 48th [&#8230;]\n","protected":false},"author":1,"featured_media":64399,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64398","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Opthea Wet AMD Data Featured at Macula Society Meeting - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opthea Wet AMD Data Featured at Macula Society Meeting\" \/>\n<meta property=\"og:description\" content=\"MELBOURNE, Australia, and PRINCETON, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Opthea Limited (ASX\/NASDAQ:OPT, \u201cOpthea\u201d, the \u201cCompany\u201d), a\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-06T12:01:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Opthea-Limited.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Opthea Wet AMD Data Featured at Macula Society Meeting\",\"datePublished\":\"2025-02-06T12:01:45+00:00\",\"dateModified\":\"2025-02-06T12:01:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/\"},\"wordCount\":354,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/\",\"name\":\"Opthea Wet AMD Data Featured at Macula Society Meeting - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-06T12:01:45+00:00\",\"dateModified\":\"2025-02-06T12:01:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opthea Wet AMD Data Featured at Macula Society Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Opthea Wet AMD Data Featured at Macula Society Meeting - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Opthea Wet AMD Data Featured at Macula Society Meeting","og_description":"MELBOURNE, Australia, and PRINCETON, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) &#8212; Opthea Limited (ASX\/NASDAQ:OPT, \u201cOpthea\u201d, the \u201cCompany\u201d), a","og_url":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-06T12:01:45+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Opthea-Limited.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Opthea Wet AMD Data Featured at Macula Society Meeting","datePublished":"2025-02-06T12:01:45+00:00","dateModified":"2025-02-06T12:01:45+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/"},"wordCount":354,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/","url":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/","name":"Opthea Wet AMD Data Featured at Macula Society Meeting - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-06T12:01:45+00:00","dateModified":"2025-02-06T12:01:45+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/opthea-wet-amd-data-featured-at-macula-society-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Opthea Wet AMD Data Featured at Macula Society Meeting"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64398"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64398\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64399"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}